TickerFacts.

Viatris Inc (VTRS): Gross Profit

Annual figures by period end, from SEC filings.

$5.01B
Year ended 2025-12-31
$5.13B
Trailing 12 months to 2026-06-30
-8.3%
3-year compound annual growth
+5.7%
5-year compound annual growth
$6.50B2018-12-31: $4.00B2019-12-31: $3.90B2020-12-31: $3.80B2021-12-31: $5.58B2022-12-31: $6.50B2023-12-31: $6.44B2024-12-31: $5.62B2025-12-31: $5.01B$5.01B
2018-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$5.01B-10.8%2026-02-26, From 2025-01-01
2024-12-31$5.62B-12.7%2026-02-26, From 2024-01-01
2023-12-31$6.44B-0.9%2026-02-26, From 2023-01-01
2022-12-31$6.50B+16.5%2025-02-27, From 2022-01-01
2021-12-31$5.58B+46.9%2024-02-28, From 2021-01-01
2020-12-31$3.80B-2.6%2023-02-27, From 2020-01-01
2019-12-31$3.90B-2.6%2022-02-28, From 2019-01-01
2018-12-31$4.00Bn/a2021-03-01, From 2018-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Viatris Inc (VTRS)2025-12-31$5.01B-10.8%
Vertex Pharmaceuticals Inc (VRTX)2025-12-31$10.35B+9.1%
Teva Pharmaceutical Industries Ltd (TEVA)2025-12-31$8.94B+10.8%
Zoetis Inc. (ZTS)2025-12-31$6.80B+4.0%
Organon & Co. (OGN)2025-12-31$3.31B-10.8%
BeOne Medicines Ltd. (ONC)2025-12-31$4.67B+45.3%
Elanco Animal Health Inc (ELAN)2025-12-31$2.59B+6.4%
Abbott Laboratories (ABT)2025-12-31$25.01B+7.6%
Perrigo Co PLC (PRGO)2025-12-31$1.49B-3.1%

Compare VTRS, VRTX, TEVA, ZTS side by side · Screen every company in Pharmaceutical Preparations ↗